chr12-62275632-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001252078.2(USP15):​c.89+15129A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.858 in 151,934 control chromosomes in the GnomAD database, including 56,168 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.86 ( 56168 hom., cov: 29)

Consequence

USP15
NM_001252078.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0270

Publications

3 publications found
Variant links:
Genes affected
USP15 (HGNC:12613): (ubiquitin specific peptidase 15) This gene encodes a member of the ubiquitin specific protease (USP) family of deubiquitinating enzymes. USP enzymes play critical roles in ubiquitin-dependent processes through polyubiquitin chain disassembly and hydrolysis of ubiquitin-substrate bonds. The encoded protein associates with the COP9 signalosome, and also plays a role in transforming growth factor beta signalling through deubiquitination of receptor-activated SMAD transcription factors. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 2. [provided by RefSeq, Nov 2011]
TAFA2 (HGNC:21589): (TAFA chemokine like family member 2) This gene is a member of the TAFA family which is composed of five highly homologous genes that encode small secreted proteins. These proteins contain conserved cysteine residues at fixed positions, and are distantly related to MIP-1alpha, a member of the CC-chemokine family. The TAFA proteins are predominantly expressed in specific regions of the brain, and are postulated to function as brain-specific chemokines or neurokines, that act as regulators of immune and nervous cells. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.92 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001252078.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
USP15
NM_001252078.2
MANE Select
c.89+15129A>G
intron
N/ANP_001239007.1Q9Y4E8-1
USP15
NM_006313.3
c.89+15129A>G
intron
N/ANP_006304.1Q9Y4E8-2
USP15
NM_001351159.2
c.-1661+15129A>G
intron
N/ANP_001338088.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
USP15
ENST00000280377.10
TSL:1 MANE Select
c.89+15129A>G
intron
N/AENSP00000280377.5Q9Y4E8-1
USP15
ENST00000353364.7
TSL:1
c.89+15129A>G
intron
N/AENSP00000258123.4Q9Y4E8-2
USP15
ENST00000312635.10
TSL:1
c.89+15129A>G
intron
N/AENSP00000309240.6Q9Y4E8-4

Frequencies

GnomAD3 genomes
AF:
0.858
AC:
130228
AN:
151816
Hom.:
56111
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.928
Gnomad AMI
AF:
0.809
Gnomad AMR
AF:
0.782
Gnomad ASJ
AF:
0.899
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.783
Gnomad FIN
AF:
0.888
Gnomad MID
AF:
0.892
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.850
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.858
AC:
130342
AN:
151934
Hom.:
56168
Cov.:
29
AF XY:
0.857
AC XY:
63611
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.928
AC:
38448
AN:
41432
American (AMR)
AF:
0.782
AC:
11910
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.899
AC:
3115
AN:
3466
East Asian (EAS)
AF:
0.708
AC:
3645
AN:
5148
South Asian (SAS)
AF:
0.784
AC:
3776
AN:
4816
European-Finnish (FIN)
AF:
0.888
AC:
9391
AN:
10576
Middle Eastern (MID)
AF:
0.898
AC:
264
AN:
294
European-Non Finnish (NFE)
AF:
0.843
AC:
57269
AN:
67952
Other (OTH)
AF:
0.850
AC:
1788
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
910
1820
2729
3639
4549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.839
Hom.:
23303
Bravo
AF:
0.853

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
4.7
DANN
Benign
0.36
PhyloP100
0.027
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7315790; hg19: chr12-62669413; API